TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: KIDNET vs Meditation/Relaxation - a Dissemination Randomized Controlled Treatment Trial for Children in Sri Lanka Traumatized by the War and the Tsunami
Brief Summary: The purpose of this study is to assess the efficacy of KIDNET versus a Meditation/Relaxation protocol in treating traumatized children in Sri Lanka when applied by locally trained teacher counsellors.


Options:
A: Arm Label: IPT arm; Type: EXPERIMENTAL; Interventions: Behavioral: interpersonal psychotherapy for groups | Arm Label: CP arm; Type: EXPERIMENTAL; Interventions: Behavioral: creative play therapy | Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: interpersonal psychotherapy for groups; Assigned to Arm(s): IPT arm | Intervention Type: BEHAVIORAL; Name: creative play therapy; Assigned to Arm(s): CP arm
B: Arm Label: Child, Parenting, & Parent Web-Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Bounce Back Now Website | Arm Label: Child & Parenting Web-Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Bounce Back Now Website | Arm Label: Child & Parent Web-based Assessment; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Bounce Back Now Website; Assigned to Arm(s): Child & Parenting Web-Intervention, Child, Parenting, & Parent Web-Intervention
C: Arm Label: Waitlist+EducAid; Type: ACTIVE_COMPARATOR; Interventions: Other: EducAid educational programming | Arm Label: Waitlist; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: YRI only; Type: EXPERIMENTAL; Interventions: Behavioral: YRI, Other: EducAid educational programming | Arm Label: YRI+EducAid; Type: EXPERIMENTAL; Interventions: Behavioral: YRI, Other: EducAid educational programming | Intervention Type: BEHAVIORAL; Name: YRI; Assigned to Arm(s): YRI only, YRI+EducAid | Intervention Type: OTHER; Name: EducAid educational programming; Assigned to Arm(s): Waitlist+EducAid, YRI only, YRI+EducAid
D: Arm Label: KIDNET; Type: EXPERIMENTAL; Interventions: Behavioral: KIDNET | Arm Label: Meditation/Relaxation; Type: EXPERIMENTAL; Interventions: Behavioral: Meditation-Relaxation | Intervention Type: BEHAVIORAL; Name: KIDNET; Assigned to Arm(s): KIDNET | Intervention Type: BEHAVIORAL; Name: Meditation-Relaxation; Assigned to Arm(s): Meditation/Relaxation

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of a Web-Assisted Quitline for Smokeless Tobacco Users
Brief Summary: The purpose of this record is to test whether (a) participants who receive a Web-based smokeless tobacco cessation intervention will be more likely to be abstinent than participants who do not receive this intervention, and (b) whether participants who receive a telephone quitline intervention will be more likely to be abstinent than participants who are not in a quitline intervention.


Options:
A: Arm Label: Web + Phone; Type: EXPERIMENTAL; Interventions: Behavioral: Web + Phone | Arm Label: Web Only; Type: EXPERIMENTAL; Interventions: Behavioral: Web Only | Arm Label: Phone Only; Type: EXPERIMENTAL; Interventions: Behavioral: Phone Only | Arm Label: Control; Type: EXPERIMENTAL; Interventions: Behavioral: Usual Care | Intervention Type: BEHAVIORAL; Name: Web + Phone; Assigned to Arm(s): Web + Phone | Intervention Type: BEHAVIORAL; Name: Web Only; Assigned to Arm(s): Web Only | Intervention Type: BEHAVIORAL; Name: Phone Only; Assigned to Arm(s): Phone Only | Intervention Type: BEHAVIORAL; Name: Usual Care; Assigned to Arm(s): Control
B: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Other: Telephone Care Coordination | Arm Label: Arm 2; Type: EXPERIMENTAL; Interventions: Other: Telephone Care Coordination with state Quitline | Intervention Type: OTHER; Name: Telephone Care Coordination; Assigned to Arm(s): Arm 1 | Intervention Type: OTHER; Name: Telephone Care Coordination with state Quitline; Assigned to Arm(s): Arm 2
C: Arm Label: Incentives; Type: EXPERIMENTAL; Interventions: Behavioral: NH Medicaid Incentives Program | Arm Label: No Incentives; Type: EXPERIMENTAL; Interventions: Behavioral: NH Medicaid Incentives Program | Intervention Type: BEHAVIORAL; Name: NH Medicaid Incentives Program; Assigned to Arm(s): Incentives, No Incentives
D: Arm Label: Gradual reduction; Type: EXPERIMENTAL; Interventions: Behavioral: Reduction Phone Counseling, Drug: Pre-Quit Nicotine Lozenges, Drug: Post-Quit Nicotine Lozenges | Arm Label: Abrupt cessation; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Abrupt Phone Counseling, Drug: Post-Quit Nicotine Lozenges | Arm Label: Minimal intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Minimal Abrupt Phone Counseling, Drug: Post-Quit Nicotine Lozenges | Intervention Type: BEHAVIORAL; Name: Reduction Phone Counseling; Assigned to Arm(s): Gradual reduction | Intervention Type: BEHAVIORAL; Name: Abrupt Phone Counseling; Assigned to Arm(s): Abrupt cessation | Intervention Type: BEHAVIORAL; Name: Minimal Abrupt Phone Counseling; Assigned to Arm(s): Minimal intervention | Intervention Type: DRUG; Name: Pre-Quit Nicotine Lozenges; Assigned to Arm(s): Gradual reduction | Intervention Type: DRUG; Name: Post-Quit Nicotine Lozenges; Assigned to Arm(s): Abrupt cessation, Gradual reduction, Minimal intervention

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of a Web-Assisted Quitline for Smokeless Tobacco Users
Brief Summary: The purpose of this record is to test whether (a) participants who receive a Web-based smokeless tobacco cessation intervention will be more likely to be abstinent than participants who do not receive this intervention, and (b) whether participants who receive a telephone quitline intervention will be more likely to be abstinent than participants who are not in a quitline intervention.


Options:
A: Intervention Type: DRUG; Name: varenicline (CP-526,555); Assigned to Arm(s): N/A
B: Arm Label: Web + Phone; Type: EXPERIMENTAL; Interventions: Behavioral: Web + Phone | Arm Label: Web Only; Type: EXPERIMENTAL; Interventions: Behavioral: Web Only | Arm Label: Phone Only; Type: EXPERIMENTAL; Interventions: Behavioral: Phone Only | Arm Label: Control; Type: EXPERIMENTAL; Interventions: Behavioral: Usual Care | Intervention Type: BEHAVIORAL; Name: Web + Phone; Assigned to Arm(s): Web + Phone | Intervention Type: BEHAVIORAL; Name: Web Only; Assigned to Arm(s): Web Only | Intervention Type: BEHAVIORAL; Name: Phone Only; Assigned to Arm(s): Phone Only | Intervention Type: BEHAVIORAL; Name: Usual Care; Assigned to Arm(s): Control
C: Intervention Type: DRUG; Name: varenicline (CP-526,555); Assigned to Arm(s): N/A
D: Arm Label: Active; Type: EXPERIMENTAL; Interventions: Drug: Varenicline Tartrate | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Varenicline Tartrate; Assigned to Arm(s): Active | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Prospective, Randomized, Controlled Trial of Rectal Indomethacin in the Prevention of Post-ERCP Pancreatitis in High Risk Patients.
Brief Summary: Pancreatitis (inflammation of the pancreas) is the most common complication of endoscopic retrograde cholangiopancreatography (ERCP), a procedure for the diagnosis and treatment of disorders of the pancreas and bile duct.

Preliminary data has shown that non-steroidal antiinflammatory drugs, when administered rectally, can reduce the risk of pancreatitis after ERCP. This study is intended to definitively determine whether rectally administered indomethacin (a non-steroidal antiinflammatory drug)is effective at preventing pancreatitis after ERCP.


Options:
A: Arm Label: Activated protein C; Type: EXPERIMENTAL; Interventions: Drug: Activated protein C | Intervention Type: DRUG; Name: Activated protein C; Assigned to Arm(s): Activated protein C
B: Arm Label: Pentoxifylline; Type: EXPERIMENTAL; Interventions: Drug: Pentoxifylline | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Pentoxifylline; Assigned to Arm(s): Pentoxifylline | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Lipidem® (BBraun); Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Lipidem (Omega-3 fish oil lipid emulsion) | Arm Label: Lipofundin® MCT/LCT 20%; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Lipofundin® MCT/LCT 20% | Intervention Type: DIETARY_SUPPLEMENT; Name: Lipidem (Omega-3 fish oil lipid emulsion); Assigned to Arm(s): Lipidem® (BBraun) | Intervention Type: DIETARY_SUPPLEMENT; Name: Lipofundin® MCT/LCT 20%; Assigned to Arm(s): Lipofundin® MCT/LCT 20%
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Indomethacin | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo suppositories | Intervention Type: DRUG; Name: Indomethacin; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: Placebo suppositories; Assigned to Arm(s): 2

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Prospective, Randomized, Controlled Trial of Rectal Indomethacin in the Prevention of Post-ERCP Pancreatitis in High Risk Patients.
Brief Summary: Pancreatitis (inflammation of the pancreas) is the most common complication of endoscopic retrograde cholangiopancreatography (ERCP), a procedure for the diagnosis and treatment of disorders of the pancreas and bile duct.

Preliminary data has shown that non-steroidal antiinflammatory drugs, when administered rectally, can reduce the risk of pancreatitis after ERCP. This study is intended to definitively determine whether rectally administered indomethacin (a non-steroidal antiinflammatory drug)is effective at preventing pancreatitis after ERCP.


Options:
A: Arm Label: 0.035 guidewire; Type: ACTIVE_COMPARATOR; Interventions: Device: Conventional 0.035 guidewire | Arm Label: Olympus Visiglide 0.025 guidewire; Type: ACTIVE_COMPARATOR; Interventions: Device: Olympus Visiglide 0.025 guidewire | Intervention Type: DEVICE; Name: Conventional 0.035 guidewire; Assigned to Arm(s): 0.035 guidewire | Intervention Type: DEVICE; Name: Olympus Visiglide 0.025 guidewire; Assigned to Arm(s): Olympus Visiglide 0.025 guidewire
B: Arm Label: loop-tip arm; Type: EXPERIMENTAL; Interventions: Device: Loop-tip wire (Cook Medical) for the cannulation of the CBD | Arm Label: Control arm; Type: ACTIVE_COMPARATOR; Interventions: Device: Cannulotome CT-25mm Cook Medical | Intervention Type: DEVICE; Name: Loop-tip wire (Cook Medical) for the cannulation of the CBD; Assigned to Arm(s): loop-tip arm | Intervention Type: DEVICE; Name: Cannulotome CT-25mm Cook Medical; Assigned to Arm(s): Control arm
C: Arm Label: A (NS+Placebo); Type: PLACEBO_COMPARATOR; Interventions: Drug: Normal Saline, Drug: Placebo | Arm Label: B (NS+IND); Type: ACTIVE_COMPARATOR; Interventions: Drug: Indomethacin, Drug: Normal Saline | Arm Label: C (LR+Placebo); Type: ACTIVE_COMPARATOR; Interventions: Drug: Lactated Ringer's Solution, Drug: Placebo | Arm Label: D (LR+IND); Type: EXPERIMENTAL; Interventions: Drug: Indomethacin, Drug: Lactated Ringer's Solution | Intervention Type: DRUG; Name: Indomethacin; Assigned to Arm(s): B (NS+IND), D (LR+IND) | Intervention Type: DRUG; Name: Lactated Ringer's Solution; Assigned to Arm(s): C (LR+Placebo), D (LR+IND) | Intervention Type: DRUG; Name: Normal Saline; Assigned to Arm(s): A (NS+Placebo), B (NS+IND) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): A (NS+Placebo), C (LR+Placebo)
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Indomethacin | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo suppositories | Intervention Type: DRUG; Name: Indomethacin; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: Placebo suppositories; Assigned to Arm(s): 2

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Endoscopic Sclerotherapy and/or Ligation Versus Portacaval Shunt for Bleeding
Brief Summary: In unselected cirrhotic patients with bleeding gastric varices to compare the influence on mortality rate, duration of life, control of bleeding, quality of life, and economic costs of treatment of: portacaval shunt, endoscopic variceal sclerotherapy and/or variceal ligation.


Options:
A: Arm Label: Injection Sclerotherapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: Injection Sclerotherapy | Arm Label: N-butyl-2-cyanoacrylate; Type: ACTIVE_COMPARATOR; Interventions: Drug: N-butyl-2-cyanoacrylate | Intervention Type: DRUG; Name: Injection Sclerotherapy; Assigned to Arm(s): Injection Sclerotherapy | Intervention Type: DRUG; Name: N-butyl-2-cyanoacrylate; Assigned to Arm(s): N-butyl-2-cyanoacrylate
B: Arm Label: EVL plus Somatostatin; Type: EXPERIMENTAL; Interventions: Drug: Somatostatin | Arm Label: EVL plus Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Somatostatin; Assigned to Arm(s): EVL plus Somatostatin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): EVL plus Placebo
C: Arm Label: Self-expandable esophageal stent; Type: ACTIVE_COMPARATOR; Interventions: Device: Stent | Arm Label: Sengstaken-Blakemore tube; Type: ACTIVE_COMPARATOR; Interventions: Device: Tamponade | Intervention Type: DEVICE; Name: Stent; Assigned to Arm(s): Self-expandable esophageal stent | Intervention Type: DEVICE; Name: Tamponade; Assigned to Arm(s): Sengstaken-Blakemore tube
D: Arm Label: Portacaval shunt; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Portacaval shunt | Arm Label: Sclerotherapy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Sclerotherapy | Intervention Type: PROCEDURE; Name: Portacaval shunt; Assigned to Arm(s): Portacaval shunt | Intervention Type: PROCEDURE; Name: Sclerotherapy; Assigned to Arm(s): Sclerotherapy

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Endoscopic Sclerotherapy and/or Ligation Versus Portacaval Shunt for Bleeding
Brief Summary: In unselected cirrhotic patients with bleeding gastric varices to compare the influence on mortality rate, duration of life, control of bleeding, quality of life, and economic costs of treatment of: portacaval shunt, endoscopic variceal sclerotherapy and/or variceal ligation.


Options:
A: Arm Label: TIPS treatment; Type: EXPERIMENTAL; Interventions: Procedure: TIPS treatment | Arm Label: Medical treatment; Type: ACTIVE_COMPARATOR; Interventions: Drug: Medical treatment | Intervention Type: PROCEDURE; Name: TIPS treatment; Assigned to Arm(s): TIPS treatment | Intervention Type: DRUG; Name: Medical treatment; Assigned to Arm(s): Medical treatment
B: Arm Label: Portacaval shunt; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Portacaval shunt | Arm Label: Sclerotherapy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Sclerotherapy | Intervention Type: PROCEDURE; Name: Portacaval shunt; Assigned to Arm(s): Portacaval shunt | Intervention Type: PROCEDURE; Name: Sclerotherapy; Assigned to Arm(s): Sclerotherapy
C: Arm Label: ET+NSBB; Type: ACTIVE_COMPARATOR; Interventions: Procedure: ET+NSBB | Arm Label: TIPS; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Transjugular intrahepatic portosystemic shunt (TIPS) | Intervention Type: PROCEDURE; Name: Transjugular intrahepatic portosystemic shunt (TIPS); Assigned to Arm(s): TIPS | Intervention Type: PROCEDURE; Name: ET+NSBB; Assigned to Arm(s): ET+NSBB
D: Arm Label: Endoscopic Variceal Band Ligation (EVBL); Type: ACTIVE_COMPARATOR; Interventions: Procedure: Endoscopic Variceal Band Ligation | Arm Label: Early TIPSS; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Endoscopic Variceal Band Ligation, Procedure: Transjugular Intrahepatic Porto-Systemic Stent Shunt | Intervention Type: PROCEDURE; Name: Endoscopic Variceal Band Ligation; Assigned to Arm(s): Early TIPSS, Endoscopic Variceal Band Ligation (EVBL) | Intervention Type: PROCEDURE; Name: Transjugular Intrahepatic Porto-Systemic Stent Shunt; Assigned to Arm(s): Early TIPSS

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Protein Levels and Caloric Density on the Growth of Formula Fed Infants From Overweight or Obese Mothers
Brief Summary: The purpose of this study is to determine whether infants, from overweight or obese mothers, fed a formula with proteins and calories different than a standard infant formula have a different growth


Options:
A: Arm Label: Lower protein formula; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Lower protein formula; Higher protein formula | Arm Label: Higher protein formula; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Lower protein formula; Higher protein formula | Arm Label: Breastfed reference group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DIETARY_SUPPLEMENT; Name: Lower protein formula; Higher protein formula; Assigned to Arm(s): Higher protein formula, Lower protein formula
B: Arm Label: Experimental formula; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Young-child formula with low protein content | Arm Label: Control formula; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Young-child formula with protein content similar to that of cow's milk | Intervention Type: DIETARY_SUPPLEMENT; Name: Young-child formula with low protein content; Assigned to Arm(s): Experimental formula | Intervention Type: DIETARY_SUPPLEMENT; Name: Young-child formula with protein content similar to that of cow's milk; Assigned to Arm(s): Control formula
C: Arm Label: 1; Type: PLACEBO_COMPARATOR; Interventions: Other: standard infant formula | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Other: Test formula | Arm Label: 3; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: standard infant formula; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: Test formula; Assigned to Arm(s): 2
D: Arm Label: Human Milk; Type: ACTIVE_COMPARATOR; Interventions: Other: Human Milk | Arm Label: Milk based standard infant formula; Type: ACTIVE_COMPARATOR; Interventions: Other: Milk based standard infant formula | Arm Label: Milk based investigational infant formula; Type: EXPERIMENTAL; Interventions: Other: Investigational infant formula | Intervention Type: OTHER; Name: Human Milk; Assigned to Arm(s): Human Milk | Intervention Type: OTHER; Name: Investigational infant formula; Assigned to Arm(s): Milk based investigational infant formula | Intervention Type: OTHER; Name: Milk based standard infant formula; Assigned to Arm(s): Milk based standard infant formula

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Treatment of Agitation in the Nursing Home
Brief Summary: The purpose of this study is to examine the efficacy of non-pharmacological ways to treat agitated behaviors in nursing home residents with dementia. The hypothesis is that non-pharmacological interventions will be more effective than placebo in decreasing such behaviors.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: TREA (Treatment Routes for Exploring Agitation) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Placebo Control Group | Intervention Type: BEHAVIORAL; Name: TREA (Treatment Routes for Exploring Agitation); Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Placebo Control Group; Assigned to Arm(s): 2
B: Intervention Type: DRUG; Name: aripiprazole; Assigned to Arm(s): N/A
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Pimavanserin 40 mg; Type: EXPERIMENTAL; Interventions: Drug: Pimavanserin tartrate | Intervention Type: DRUG; Name: Pimavanserin tartrate; Assigned to Arm(s): Pimavanserin 40 mg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Audit + Feedback; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Audit + Feedback | Arm Label: Audit + Feedback + Educational Outreach; Type: EXPERIMENTAL; Interventions: Behavioral: Audit + Feedback, Behavioral: Audit + Feedback + Educational Outreach | Intervention Type: BEHAVIORAL; Name: Audit + Feedback; Assigned to Arm(s): Audit + Feedback, Audit + Feedback + Educational Outreach | Intervention Type: BEHAVIORAL; Name: Audit + Feedback + Educational Outreach; Assigned to Arm(s): Audit + Feedback + Educational Outreach

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Treatment of Agitation in the Nursing Home
Brief Summary: The purpose of this study is to examine the efficacy of non-pharmacological ways to treat agitated behaviors in nursing home residents with dementia. The hypothesis is that non-pharmacological interventions will be more effective than placebo in decreasing such behaviors.


Options:
A: Arm Label: Paracetamol or buprenorphine treatment; Type: ACTIVE_COMPARATOR; Interventions: Drug: Paracetamol, Drug: Buprenorphine | Arm Label: Paracetamol placebo or buprenorphine placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Paracetamol placebo, Drug: Buprenorphine placebo | Intervention Type: DRUG; Name: Paracetamol; Assigned to Arm(s): Paracetamol or buprenorphine treatment | Intervention Type: DRUG; Name: Buprenorphine; Assigned to Arm(s): Paracetamol or buprenorphine treatment | Intervention Type: DRUG; Name: Paracetamol placebo; Assigned to Arm(s): Paracetamol placebo or buprenorphine placebo | Intervention Type: DRUG; Name: Buprenorphine placebo; Assigned to Arm(s): Paracetamol placebo or buprenorphine placebo
B: Arm Label: Treatment as usual; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Paracetamol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Paracetamol | Arm Label: Morphine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Morphine | Arm Label: Buprenorphine plaster; Type: ACTIVE_COMPARATOR; Interventions: Drug: Buprenorphine plaster | Arm Label: Pregabalin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Pregabalin | Intervention Type: DRUG; Name: Paracetamol; Assigned to Arm(s): Paracetamol | Intervention Type: DRUG; Name: Morphine; Assigned to Arm(s): Morphine | Intervention Type: DRUG; Name: Buprenorphine plaster; Assigned to Arm(s): Buprenorphine plaster | Intervention Type: DRUG; Name: Pregabalin; Assigned to Arm(s): Pregabalin
C: Arm Label: Algorithm; Type: EXPERIMENTAL; Interventions: Behavioral: Algorithm | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Algorithm | Intervention Type: BEHAVIORAL; Name: Algorithm; Assigned to Arm(s): Algorithm, Control
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: TREA (Treatment Routes for Exploring Agitation) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Placebo Control Group | Intervention Type: BEHAVIORAL; Name: TREA (Treatment Routes for Exploring Agitation); Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Placebo Control Group; Assigned to Arm(s): 2

Answer: D